Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mereo Biopharma Group Plc (MREO)
NASDAQ:MREO
RESEARCH TOOLSreports
Holding MREO?
Track your performance easily
Mereo Biopharma Group Plc (MREO) Ownership Overview
1.70% Insiders
0.10% Mutual Funds
51.35% Other Institutional Investors
0.59% ETFs
46.25% Public Companies and
Individual Investors
The ownership structure of Mereo Biopharma Group Plc (MREO) stock is a mix of institutional, retail, and individual investors. Approximately 52.05% of the company’s stock is owned by Institutional Investors, 1.70% is owned by Insiders, and 46.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 16, 2024 | Hughes Wilson Alexandra Chief Patient Access And Commercial Planning | xxxxxxxxxxxxx | $533443 |
| Aug 23, 2024 | Deepika Pakianathan Director | xxxxxxxxxxxxx | $465178 |
| Nov 30, 2023 | Denise Scots Knight Chief Executive Officer | xxxxxxxxxxxxx | $294000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $52192 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $3352617 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,710,429 | Institution | 4.33% | 24,962,796 | |
| 839,420 | Institution | 0.54% | 3,122,642 | |
| 815,722 | Institution | 0.53% | 3,034,486 | |
| 808,921 | Insider | 0.52% | 3,009,186 | |
| 775,728 | Insider | 0.50% | 2,885,708 | |
| 560,413 | Insider | 0.36% | 2,084,736 | |
| 219,061 | Insider | 0.14% | 814,907 | |
| 92,826 | Insider | 0.06% | 345,313 | |
| 92,156 | Institution | 0.06% | 342,820 | |
| 89,285 | Insider | 0.06% | 332,140 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 92,156 | Institution | 0.06% | 342,820 | |
| 55,903 | Institution | 0.04% | 207,959 | |
| 10,000 | Institution | <0.01% | 37,200 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 524,031 | Institution | 0.34% | 1,928,434 | |
| 315,389 | Institution | 0.20% | 1,160,632 | |
| 47,085 | Institution | 0.03% | 173,273 | |
| 31,139 | Institution | 0.02% | 114,592 |
FAQ
Who Owns Mereo Biopharma Group Plc (MREO)?
According to the latest TipRanks data, approximately 51.35% of the company's stock is held by institutional investors, 1.70% is held by insiders, and 46.25% is held by retail investors.
What percentage of Mereo Biopharma Group Plc (MREO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 51.35% of Mereo Biopharma Group Plc (MREO) stock is held by institutional investors.
What percentage of Mereo Biopharma Group Plc (MREO) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.25% of Mereo Biopharma Group Plc (MREO) stock is held by retail investors.
Who owns the most shares of Mereo Biopharma Group Plc (MREO)?
James E. Flynn owns the most shares of Mereo Biopharma Group Plc (MREO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.